Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma

doi:10.3748/wjg.v25.i21.2636

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 21

This Article

(317)

(279)

(0)

(13)

(6878)

(11)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Case Control Study

World J Gastroenterol. Jun 7, 2019; 25(21): 2636-2649
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2636

Table 2 Imaging characteristics compared between the pathologic stage T2 group and T1 group, n (%)

Characteristics	pT2, n = 39	pT1, n = 75	P value
T2 hyperintensity	37 (94.9)	68 (90.7)	0.716
T1 hypointensity	35 (89.7)	69 (92.0)	0.733
Arterial enhancement	38 (97.4)	70 (93.3)	0.662
Corona enhancement	14 (35.9)	13 (17.3)	0.037
Washout appearance	36 (92.3)	69 (92.0)	1.000
Capsular appearance	14 (35.9)	38 (50.7)	0.167
Hypointensity of tumor in the HB phase	37 (94.9)	74 (98.7)	0.269
Peritumoral hypointensity in the HB phase	16 (41.0)	18 (24.0)	0.084
Hypointense-rim in the HB phase	5 (12.8)	21 (28.0)	0.099
Intratumoral fat	8 (20.5)	18 (24.0)	0.815
Hyperintensity on DWI	39 (100.0)	72 (96.0)	0.550
Hypointensity on ADC map	16 (41.0)	32 (42.7)	1.000
Mosaic architecture	27 (69.2)	48 (64.0)	0.679
Margin type			0.503
Smooth	27 (69.2)	57 (76.0)
Irregular	12 (30.8)	18 (24.0)
AJCC v.7	39 (100.0)	75 (100.0)
AJCC v.8			0.005
cT1a (≤ 2 cm)	3 (7.7)	24 (32.0)
cT1b (> 2 cm)	36 (92.3)	51 (68.0)

HB: Hepatobiliary; DWI: Diffusion weighted imaging; ADC: Apparent diffusion coefficient; AJCC: American Joint Committee on Cancer; pT1: Pathologic stage T1; pT2: Pathologic stage T2.

Full Size Table

Citation: Chou YC, Lao IH, Hsieh PL, Su YY, Mak CW, Sun DP, Sheu MJ, Kuo HT, Chen TJ, Ho CH, Kuo YT. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma. World J Gastroenterol 2019; 25(21): 2636-2649
URL: https://www.wjgnet.com/1007-9327/full/v25/i21/2636.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i21.2636

Chou YC, Lao IH, Hsieh PL, Su YY, Mak CW, Sun DP, Sheu MJ, Kuo HT, Chen TJ, Ho CH, Kuo YT. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma. World J Gastroenterol 2019; 25(21): 2636-2649 [PMID: 31210715 DOI: 10.3748/wjg.v25.i21.2636]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.